Valuation: Terumo Corporation

Market Cap 3,360B 21.31B 18.8B 17.79B 16.13B 30.25B 2,044B 30.55B 213B 82.25B 1,044B 80B 78.26B P/E 2027 *
17.6x
P/E 2028 * 17.4x
Enterprise Value 3,406B 21.6B 19.06B 18.03B 16.35B 30.66B 2,072B 30.96B 216B 83.38B 1,058B 81.1B 79.33B EV / Sales 2027 *
2.7x
EV / Sales 2028 * 2.48x
Free-Float
97.34%
Yield 2027 *
1.62%
Yield 2028 * 1.76%
1 day+0.26%
1 week+1.76%
Current month-9.48%
1 month-10.30%
3 months+2.96%
6 months+6.85%
Current year+0.33%
1 week 2,230
Extreme 2230
2,309.5
1 month 2,194.5
Extreme 2194.5
2,555
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,689
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.26%+1.76%-6.95%+15.96% 21.46B
-0.87%-3.72%-25.00%+3.08% 175B
-2.78%-4.16%-7.42%+11.02% 114B
-0.03%-3.48%-1.49%+68.64% 57.98B
-1.62%-1.16%-1.70%-30.04% 50.07B
-1.00%+2.74%+13.85%+53.00% 50.13B
-1.04%-4.23%+29.01%-8.10% 32.71B
-0.74%+1.26% - - 30.77B
-0.44%+0.93%+43.88%-0.18% 26.44B
+0.28%+5.23%+26.98%-3.89% 23.96B
Average -0.80%+1.66%+7.91%+12.17% 58.27B
Weighted average by Cap. -1.13%-0.09%-3.78%+12.52%

Financials

2027 *2028 *
Net sales 1,261B 7.99B 7.06B 6.68B 6.05B 11.35B 767B 11.46B 80.08B 30.86B 392B 30.02B 29.37B 1,342B 8.51B 7.51B 7.1B 6.44B 12.08B 816B 12.2B 85.22B 32.85B 417B 31.95B 31.25B
Net income 191B 1.21B 1.07B 1.01B 915M 1.72B 116B 1.73B 12.1B 4.66B 59.2B 4.54B 4.44B 193B 1.22B 1.08B 1.02B 926M 1.74B 117B 1.75B 12.25B 4.72B 59.9B 4.59B 4.49B
Net Debt 45.99B 292M 257M 244M 221M 414M 27.99B 418M 2.92B 1.13B 14.29B 1.1B 1.07B -26.39B -167M -148M -140M -127M -238M -16.06B -240M -1.68B -646M -8.2B -629M -615M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
29/09/26 ¥2,277.50 +0.26% 4,840,400
28/09/26 ¥2,289.50 -0.30% 5,905,500
25/09/26 ¥2,296.50 +0.97% 5,424,500
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,277.50JPY
Average target price
3,110.00JPY
Spread / Average Target
+36.55%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock